177 related articles for article (PubMed ID: 24678088)
1. Estimation of minimum whole-blood tacrolimus concentration for therapeutic drug monitoring with plasma prednisolone concentration: A retrospective cohort study in Japanese kidney transplant recipients.
Sugioka N; Matsushita A; Kokuhu T; Bpharm ; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
Curr Ther Res Clin Exp; 2006 Mar; 67(2):103-17. PubMed ID: 24678088
[TBL] [Abstract][Full Text] [Related]
2. The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients.
Sukkha S; Chindavijak B; Nosoongnoen W; Phakdeekitchareon B; Kitiyakara C; Sumethkul V
Drug Metab Pharmacokinet; 2020 Feb; 35(1):139-144. PubMed ID: 31727575
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
4. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study.
Sukkha S; Chindavijak B; Montakantikul P; Ingsathit A; Nosoongnoen W; Sumethkul V
Int J Clin Pharm; 2017 Dec; 39(6):1298-1303. PubMed ID: 29101615
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Profile of Twice- and Once-daily Tacrolimus in Pediatric Kidney Transplant Recipients.
Takahashi Y; Shishido S; Hyodo Y; Yonekura T; Nihei H; Itabashi Y; Muramatsu M; Hamasaki Y; Kawamura T; Aikawa A
Transplant Proc; 2017; 49(1):37-40. PubMed ID: 28104153
[TBL] [Abstract][Full Text] [Related]
6. Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study.
Lapeyraque AL; Kassir N; Théorêt Y; Krajinovic M; Clermont MJ; Litalien C; Phan V
Pediatr Nephrol; 2014 Jun; 29(6):1081-8. PubMed ID: 24435759
[TBL] [Abstract][Full Text] [Related]
7. Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus.
Chanoine S; Gautier-Veyret E; Pluchart H; Tonini J; Fonrose X; Claustre J; Bedouch P; Stanke-Labesque F
Br J Clin Pharmacol; 2021 Feb; 87(2):427-435. PubMed ID: 32472569
[TBL] [Abstract][Full Text] [Related]
8. Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients.
Stifft F; Undre N; van Hooff JP; Christiaans MH
Ther Drug Monit; 2016 Aug; 38(4):456-62. PubMed ID: 27128604
[TBL] [Abstract][Full Text] [Related]
9. Area under the curve of tacrolimus using microsampling devices: towards precision medicine in solid organ transplantation?
Couette A; Tron C; Golbin L; Franck B; Houssel-Debry P; Frouget T; Morin MP; Brenier H; Rayar M; Verdier MC; Vigneau C; Chemouny J; Lemaitre F
Eur J Clin Pharmacol; 2023 Nov; 79(11):1549-1556. PubMed ID: 37725122
[TBL] [Abstract][Full Text] [Related]
10. Gender-dependent predictable pharmacokinetic method for tacrolimus exposure monitoring in kidney transplant patients.
Velickovic-Radovanovic R; Mikov M; Catic-Djordjevic A; Stefanovic N; Mitic B; Paunovic G; Cvetkovic T
Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):95-102. PubMed ID: 24596067
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin AUC
Brandon HH; Burgess DS; Wallace KL; Autry EB; Olney KB
Pharmacotherapy; 2024 Apr; 44(4):294-300. PubMed ID: 38533999
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus.
Enokiya T; Nishikawa K; Muraki Y; Iwamoto T; Kanda H; Sugimura Y; Okuda M
J Pharm Health Care Sci; 2017; 3():17. PubMed ID: 28652924
[TBL] [Abstract][Full Text] [Related]
15. Intra- and interindividual variation in the pharmacokinetics of tacrolimus (FK506) in kidney transplant recipients--importance of trough level as a practical indicator.
Ihara H; Shinkuma D; Ichikawa Y; Nojima M; Nagano S; Ikoma F
Int J Urol; 1995 Jul; 2(3):151-5. PubMed ID: 8536129
[TBL] [Abstract][Full Text] [Related]
16. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
[TBL] [Abstract][Full Text] [Related]
17. Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study.
Sukkha S; Suansanae T; Iamrahong P; Wiwattanathum P
Transplant Proc; 2020 Apr; 52(3):775-779. PubMed ID: 32143870
[TBL] [Abstract][Full Text] [Related]
18. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
Niioka T; Satoh S; Kagaya H; Numakura K; Inoue T; Saito M; Narita S; Tsuchiya N; Habuchi T; Miura M
Transplantation; 2012 Nov; 94(10):1013-9. PubMed ID: 23073468
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients.
Francke MI; Hesselink DA; Li Y; Koch BCP; de Wit LEA; van Schaik RHN; Yang L; Baan CC; van Gelder T; de Winter BCM
Br J Clin Pharmacol; 2021 Apr; 87(4):1918-1929. PubMed ID: 33025649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
